References and Notes
<A NAME="RW24106ST-1A">1a</A>
Agami C.
Couty F.
Eur. J. Org. Chem.
2004,
677
<A NAME="RW24106ST-1B">1b</A>
Agami C.
Comesse S.
Kadouri-Puchot C.
J. Org. Chem.
2002,
67:
1496
<A NAME="RW24106ST-1C">1c</A>
Adam W.
Schambony SB.
Org. Lett.
2001,
3:
79
<A NAME="RW24106ST-1D">1d</A>
Iwata A.
Tang H.
Kunai A.
Ohshita J.
Yamamoto Y.
Matui C.
J. Org. Chem.
2002,
67:
5170
<A NAME="RW24106ST-2A">2a</A>
Monge A.
Aldana I.
Cerecetto H.
Rivero A.
J. Heterocycl. Chem.
1995,
32:
1429
<A NAME="RW24106ST-2B">2b</A>
Moloney GP.
Craik DJ.
Iskander MN.
Nero TL.
J. Chem. Soc., Perkin Trans. 2
1998,
199
<A NAME="RW24106ST-2C">2c</A>
Chung SJ.
Chung S.
Lee HS.
Kim EJ.
Oh KS.
Chol HS.
Kim KS.
Kim YJ.
Hahn JH.
Kim D.
J. Org. Chem.
2001,
66:
6462
<A NAME="RW24106ST-3A">3a</A>
Allin SM.
Hodkinson CC.
Taj N.
Synlett
1996,
781
<A NAME="RW24106ST-3B">3b</A>
Yli-Kauhaluoma JT.
Harwig CW.
Wentworth JP.
Tetrahedron Lett.
1998,
39:
2269
<A NAME="RW24106ST-4A">4a</A>
Nishitani T.
Shiraishi H.
Sakaguchi S.
Ishii Y.
Tetrahedron Lett.
2000,
41:
3389
<A NAME="RW24106ST-4B">4b</A>
Huo CD.
Wei R.
Zhang W.
Yang L.
Liu ZL.
Synlett
2005,
161
<A NAME="RW24106ST-5A">5a</A>
Curini M.
Epifano F.
Marcotullio MC.
Rosati O.
Tetrahedron Lett.
2001,
42:
3193
<A NAME="RW24106ST-5B">5b</A>
Li JJ.
Su WK.
Lin JD.
Chen M.
Li J.
Synth. Commun.
2005,
35:
1929
<A NAME="RW24106ST-5C">5c</A>
Curini M.
Epifano F.
Maltese F.
Rosati O.
Tetrahedron Lett.
2002,
43:
4895
<A NAME="RW24106ST-6A">6a</A>
Su WK.
Li JJ.
Zheng ZG.
Shen YC.
Tetrahedron Lett.
2005,
46:
6037
<A NAME="RW24106ST-6B">6b</A>
Su WK.
Hong Z.
Shan WG.
Zhang XX.
Eur. J. Org. Chem.
2006,
2723
<A NAME="RW24106ST-6C">6c</A>
Chen JX.
Wu HY.
Zheng ZG.
Jin C.
Zhang XX.
Su WK.
Tetrahedron Lett.
2006,
47:
5383
<A NAME="RW24106ST-7">7</A>
5-Chloromethyl-2,3-diphenyloxazolidine (
3a): MS (EI): m/z (%) = 273 (100), 196 (84), 132 (67); IR (film): 1297, 1207, 1109 cm-
1; 1H NMR (400 MHz, CDCl3):
δ (cis-3a) = 7.48-7.36 (m, 5 H), 7.16 (t, J = 7.6 Hz, 2 H), 6.75 (t, J = 7.6 Hz, 1 H), 6.52 (d, J = 7.6 Hz, 2 H), 5.87 (s, 1 H), 4.59-4.50 (m, 1 H), 3.96 (dd, J = 6.0, 8.4 Hz, 1 H), 3.85-3.59 (m, 2 H), 3.51 (dd, J = 8.4, 8.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3-TMS): δ (cis-3a) = 145.4, 139.3, 129.1, 128.9, 128.8, 127.1, 118.2, 113.9, 92.9, 76.7, 52.2, 44.6;
1H NMR (400 MHz, CDCl3): δ (trans-3a) = 7.48-7.36 (m, 5 H), 7.16 (t, J = 7.6 Hz, 2 H), 6.75 (t, J = 7.6 Hz, 1 H), 6.52 (d, J = 7.6 Hz, 2 H), 6.01 (s, 1 H), 4.59-4.50 (m, 1 H), 3.98 (dd, J = 6.0, 8.4 Hz, 1 H), 3.85-3.59 (m, 2 H), 3.51 (dd, J = 8.4, 8.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3-TMS): δ (trans-3a) = 145.2, 139.5, 129.1, 129.0, 128.7, 126.8, 117.9, 113.0, 92.4, 75.2, 51.2, 44.2;
Anal. Calcd for C16H16ClNO: C, 70.20; H, 5.89; N, 5.12. Found: C, 70.22; H, 5.90; N, 5.10.
5-Chloromethyl-2,2-diphenyl-3-
p
-tolyloxazolidine (
3i): yellow crystals; mp 125-128 °C; MS (EI): m/z (%) = 363 (22), 286 (64), 146 (100); IR (film): 1322, 1200, 1106 cm-
1; 1H NMR (400 MHz, CDCl3): δ = 7.50-7.24 (m, 10 H), 6.81 (d, J = 8.0 Hz, 2 H), 6.37 (d, J = 8.0 Hz, 2 H), 4.40-4.34 (m, 1 H), 3.84-3.67 (m, 4 H), 2.15 (s, 3 H); 13C NMR (100 MHz, CDCl3-TMS): δ = 142.4, 141.2, 140.5, 129.2, 129.0, 128.8, 128.5, 128.3, 127.9, 126.8, 114.8,
99.7, 74.1, 52.0, 44.7, 20.2; Anal. Calcd for C23H22ClNO: C, 75.92; H, 6.09; N, 3.85. Found: C, 75.90; H, 6.10; N, 3.84.
<A NAME="RW24106ST-8">8</A>
Bulatova OF.
Chalova OB.
Rakhmankulov DL.
Russ. J. Org. Chem.
2001,
37:
1753
<A NAME="RW24106ST-9">9</A> It has been reported that in the 1H NMR data for the cis configuration of 3a and 3d, the proton in the 2-position appeared at δ = 5.85 and δ = 5.84 ppm, respectively;
see:
Bulatova OF.
Chalova OB.
Rakhmankulov DL.
Russ. J. Org. Chem.
2001,
37:
1753
<A NAME="RW24106ST-10">10</A>
A mixture of epoxide 1a (0.28 g, 3 mmol), N-arylimine 2a (0.36 g, 2 mmol), and Yb(OTf)3 (0.06 g, 5 mol%) was stirred at 40 °C for 8 h. After complete conversion into 3a, as indicated by TLC, the reaction mixture was purified by silica gel column chromatography
using PE-EtOAc (10:1) as eluent to afford the pure product 5-chloromethyl-2,3-diphenyloxazolidine
(3a, 0.46 g, 85%, Table
[2]
).
<A NAME="RW24106ST-11">11</A>
Bynatoba OQ.
Pomahob HA.
Zh. Org. Khim.
1997,
16:
3658
<A NAME="RW24106ST-12">12</A>
HPLC conditions: Chiracel OD 4.6 × 250mm, hexane-
i-PrOH (85:15), 25 °C.
<A NAME="RW24106ST-13A">13a</A>
Larksarp C.
Alper H.
J. Am. Chem. Soc.
1997,
119:
3709
<A NAME="RW24106ST-13B">13b</A>
Larksarp C.
Alper H.
J. Org. Chem.
1998,
63:
6229
<A NAME="RW24106ST-13C">13c</A>
Takaya H.
Mashima K.
Koyano K.
Yagi M.
Kumobayashi H.
Taketomi T.
Akutagawa S.
Noyori R.
J. Org. Chem.
1986,
51:
629
<A NAME="RW24106ST-13D">13d</A>
Miyashita A.
Yasuda A.
Takay H.
Toriumi K.
Ito T.
Souchi Y.
Noyori R.
J. Am. Chem. Soc.
1980,
102:
7932